Increasing detection and treatment for atrial fibrillation
We are working to prevent Atrial Fibrillation (AF) related strokes and associated mortality and morbidity by supporting clinical commissioning groups (CCGs) to improve care pathways for people with AF.
AF is a common type of irregular health rhythm that can increase risk of stroke. AF affects around a 1.2 million people in the UK and is associated with one in five strokes. However, up to 25% of people with AF remain undiagnosed and there is variability in the proportion of people with AF who are prescribed anticoagulant therapy, which can help to reduce risk of stroke.
By March 2020, our AF programme aims to:
- Improve early detection of AF. One of the ways we will do this is by supporting the roll out of NHS England funded AF detection devices, to achieve 85% of expected prevalence in all CCGs
- Support initiation of anticoagulation in people with AF who are at risk of stroke to achieve 84% treatment in all CCGs
- Optimise patient pathways to facilitate early diagnosis and treatment, and support improved adherence to treatment long-term
Read more about our six current work streams.
For more information, please contact Hawa Choudhury, Project Lead for Atrial Fibrillation, Hawa.Choudhury@uclpartners.com